Xencor (XNCR) Interest & Investment Income (2013 - 2026)
Xencor's (XNCR) quarterly Interest & Investment Income came in at $5.5 million in Q1 2026, down 27.58% year-on-year from $7.5 million in Q1 2025, and down 11.95% on a QoQ basis from $6.2 million in Q4 2025.
Xencor (XNCR) Interest & Investment Income (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 10 years of Interest & Investment Income data on file, last reported at $5.5 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 27.58% year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $25.4 million, a 17.71% decrease from a year earlier, with the FY2025 full-year figure at $27.5 million, down 13.8% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $5.5 million, down from $6.2 million in the prior quarter.
- Over the last five years, Interest & Investment Income for XNCR reached as high as $8.5 million in Q1 2024 and fell as low as $2.9 million in Q1 2023.
- Historically, Interest & Investment Income has averaged $6.8 million across 4 years, with a median of $7.4 million in 2024.
- Across the five-year window, Interest & Investment Income jumped 194.86% in 2024 and declined 27.58% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $2.9 million in 2023, then jumped by 181.61% to $8.2 million in 2024, then decreased by 24.06% to $6.2 million in 2025, then declined by 11.95% to $5.5 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $5.5 million in Q1 2026, $6.2 million in Q4 2025, and $6.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 5.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Mar 31, 2025 | 7.54 Mn |
| Dec 31, 2024 | 8.16 Mn |
| Sep 30, 2024 | 7.54 Mn |
| Jun 30, 2024 | 7.68 Mn |
| Mar 31, 2024 | 8.55 Mn |
| Mar 31, 2023 | 2.90 Mn |
| Jun 30, 2018 | 2.49 Mn |
| Mar 31, 2018 | 1.16 Mn |
| Dec 31, 2017 | 1.05 Mn |
| Sep 30, 2017 | 1.05 Mn |
| Jun 30, 2017 | 1.04 Mn |
| Mar 31, 2017 | 1.06 Mn |
| Dec 31, 2016 | 785,000.00 |
| Sep 30, 2016 | 579,000.00 |
| Jun 30, 2016 | 368,000.00 |
| Mar 31, 2016 | 359,000.00 |